Nestorone(醋酸雌甾醇)对神经再生的影响

IF 6.5 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM Frontiers in Neuroendocrinology Pub Date : 2024-04-01 DOI:10.1016/j.yfrne.2024.101136
Regine Sitruk-Ware , Heather Sussman , Roberta Brinton , Michael Schumacher , Patrick Singer , Narender Kumar , Alejandro F. De Nicola , Martine El-Etr , Rachida Guennoun , Cesar V Borlongan
{"title":"Nestorone(醋酸雌甾醇)对神经再生的影响","authors":"Regine Sitruk-Ware ,&nbsp;Heather Sussman ,&nbsp;Roberta Brinton ,&nbsp;Michael Schumacher ,&nbsp;Patrick Singer ,&nbsp;Narender Kumar ,&nbsp;Alejandro F. De Nicola ,&nbsp;Martine El-Etr ,&nbsp;Rachida Guennoun ,&nbsp;Cesar V Borlongan","doi":"10.1016/j.yfrne.2024.101136","DOIUrl":null,"url":null,"abstract":"<div><p>Nestorone® (segesterone acetate) is a progestin with a chemical structure closely related to progesterone with high affinity and selectivity for the progesterone receptor without significant interaction with other steroid receptors. It has been developed for female and male contraception and is FDA-approved in a first long-acting contraceptive vaginal system for female contraception. Its safety has been extensively demonstrated in both preclinical and clinical studies for contraceptive indications. Nestorone was found to display neuroprotective and neuroregenerative activity in animal models of various central nervous system diseases, including multiple sclerosis, stroke, and amyotrophic lateral sclerosis. Reviewed herein are neuroprotective and myelin- regenerating properties of Nestorone in various animal models and its translational potential as a therapeutic agent for debilitating neurological diseases for which limited therapeutic options are available (<span>Table 1</span>).</p></div>","PeriodicalId":12469,"journal":{"name":"Frontiers in Neuroendocrinology","volume":"73 ","pages":"Article 101136"},"PeriodicalIF":6.5000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nestorone (segesterone acetate) effects on neuroregeneration\",\"authors\":\"Regine Sitruk-Ware ,&nbsp;Heather Sussman ,&nbsp;Roberta Brinton ,&nbsp;Michael Schumacher ,&nbsp;Patrick Singer ,&nbsp;Narender Kumar ,&nbsp;Alejandro F. De Nicola ,&nbsp;Martine El-Etr ,&nbsp;Rachida Guennoun ,&nbsp;Cesar V Borlongan\",\"doi\":\"10.1016/j.yfrne.2024.101136\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Nestorone® (segesterone acetate) is a progestin with a chemical structure closely related to progesterone with high affinity and selectivity for the progesterone receptor without significant interaction with other steroid receptors. It has been developed for female and male contraception and is FDA-approved in a first long-acting contraceptive vaginal system for female contraception. Its safety has been extensively demonstrated in both preclinical and clinical studies for contraceptive indications. Nestorone was found to display neuroprotective and neuroregenerative activity in animal models of various central nervous system diseases, including multiple sclerosis, stroke, and amyotrophic lateral sclerosis. Reviewed herein are neuroprotective and myelin- regenerating properties of Nestorone in various animal models and its translational potential as a therapeutic agent for debilitating neurological diseases for which limited therapeutic options are available (<span>Table 1</span>).</p></div>\",\"PeriodicalId\":12469,\"journal\":{\"name\":\"Frontiers in Neuroendocrinology\",\"volume\":\"73 \",\"pages\":\"Article 101136\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Neuroendocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0091302224000165\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Neuroendocrinology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091302224000165","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

Nestorone® (醋酸segesterone)是一种孕激素,其化学结构与黄体酮密切相关,对黄体酮受体具有高亲和力和选择性,与其他类固醇受体无明显相互作用。它已被开发用于女性和男性避孕,并被美国食品及药物管理局批准用于女性避孕的首个长效避孕阴道系统。其安全性已在避孕适应症的临床前研究和临床研究中得到广泛证实。在多种中枢神经系统疾病(包括多发性硬化症、中风和肌萎缩性脊髓侧索硬化症)的动物模型中,发现 Nestorone 具有神经保护和神经再生活性。本文综述了 Nestorone 在各种动物模型中的神经保护和髓鞘再生特性,以及它作为一种治疗剂用于治疗衰弱性神经系统疾病的转化潜力(表 1)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Nestorone (segesterone acetate) effects on neuroregeneration

Nestorone® (segesterone acetate) is a progestin with a chemical structure closely related to progesterone with high affinity and selectivity for the progesterone receptor without significant interaction with other steroid receptors. It has been developed for female and male contraception and is FDA-approved in a first long-acting contraceptive vaginal system for female contraception. Its safety has been extensively demonstrated in both preclinical and clinical studies for contraceptive indications. Nestorone was found to display neuroprotective and neuroregenerative activity in animal models of various central nervous system diseases, including multiple sclerosis, stroke, and amyotrophic lateral sclerosis. Reviewed herein are neuroprotective and myelin- regenerating properties of Nestorone in various animal models and its translational potential as a therapeutic agent for debilitating neurological diseases for which limited therapeutic options are available (Table 1).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Neuroendocrinology
Frontiers in Neuroendocrinology 医学-内分泌学与代谢
CiteScore
13.30
自引率
6.80%
发文量
62
审稿时长
68 days
期刊介绍: Frontiers in Neuroendocrinology (FIN) publishes a wide range of informative articles including comprehensive reviews, systematic reviews, opinion pieces, and meta-analyses. While the majority of reviews are invited, we also embrace unsolicited reviews and meta-analyses, as well as proposals for thematic special issues, provided they meet our rigorous quality standards. In addition, we encourage authors to submit commentaries that concisely present fresh ideas or offer further analysis to delve deeper into the implications of an article published in our journal.
期刊最新文献
Unraveling sex differences in maternal and paternal care impacts on social behaviors and neurobiological responses to early-life adversity. Insulin-like growth factor-1 and cognitive health: Exploring cellular, preclinical, and clinical dimensions Progestagens and progesterone receptor modulation: Effects on the brain, mood, stress, and cognition in females Editorial Board Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1